Paul F. Harron Jr. Lung Center

Adult Cystic Fibrosis and Bronchiectasis: The Penn Difference

The Harron Lung Center is leading care for adult cystic fibrosis, bronchiectasis, and related pulmonary diseases beyond the limits of conventional medicine by offering patients more options to improve their lives.

  • Penn Medicine has a well-established relationship with the Children's Hospital of Philadelphia (CHOP) and has helped hundreds of patients transition from pediatric care into the Adult Cystic Fibrosis and Bronchiectasis Program.
  • Penn's health care professionals understand the emerging needs of young adult patients and work closely with related specialists to address those needs.
  • Penn's Lung Transplant Program is one of the premier lung transplant programs in the country with outcomes that meet or exceed the national average.
  • Penn genetic counselors advise patients interested in having children about the genetic risks of cystic fibrosis.
  • Patients receive treatment and counseling within a comprehensive lung center. The single location contributes to a seamless continuum of care.
  • Patient care teams at the Harron Lung Center include physicians, advanced nurse practitioners, physical therapists, respiratory therapists, social workers and dietitians.
  • The team coordinates patient care to ensure that all patient needs are addressed.
  • Penn's patient care teams consult with other specialties as needed, including endocrinology, gastroenterology, infectious diseases and otorhinolaryngology.
  • Adult Cystic Fibrosis and Bronchiectasis Program is the largest program in the mid-Atlantic region and one of the largest in the country.
  • The adult CF program at Penn Medicine is accredited by the Cystic Fibrosis Foundation (CFF).
  • Penn physicians are heavily involved in research to treat cystic fibrosis, bronchiectasis and related pulmonary diseases. Patients may be eligible to participate in clinical trials, giving them access to treatments before they become widely available.